CASTLE BIOSCIENCES INC Annual Income Tax Expense (Benefit) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Castle Biosciences Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
  • Castle Biosciences Inc Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $6.01M.
  • Castle Biosciences Inc Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $5.06M.
  • Castle Biosciences Inc annual Income Tax Expense (Benefit) for 2023 was $101K.
  • Castle Biosciences Inc annual Income Tax Expense (Benefit) for 2022 was -$1.77M.
  • Castle Biosciences Inc annual Income Tax Expense (Benefit) for 2021 was -$8.72M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $101K +$1.87M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$1.77M +$6.95M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$8.72M* -$8.8M Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $84K +$12K +16.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $72K +$63K +700% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $9K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.